White House Responds After Judges Reject Alina Habba for US Attorney Post
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
The White House threw its support behind Alina Habba, President Donald Trump's former personal defense attorney and interim U.S. attorney in New Jersey, after federal judges in the state declined to extend Habba's term as the interim top prosecutor.
"President Trump has full confidence in Alina Habba, whose work as acting U.S. Attorney for the District of New Jersey has made the Garden State and the nation safer," Harrison Fields, a White House spokesperson, told Newsweek in a statement. "The Trump Administration looks forward to her final confirmation in the U.S. Senate and will work tirelessly to ensure the people of New Jersey are well represented."
The Context
The White House's statement came after Chief Judge Renée Bumb in New Jersey issued a brief order stating that the panel of judges would not extend Habba's tenure as interim U.S. attorney.
The district court appointed Desiree Leigh Grace "effective July 22, 2025, or 'upon the expiration of 120 days after appointment by the Attorney General' of the Interim U.S. Attorney Alina Habba, whichever is later," Bumb's order said.
What To Know
Tuesday's decision from the court came after Deputy Attorney General Todd Blanche issued a statement Monday urging the judges to leave Habba in place.
"In light of the smear campaign, it's worth repeating @USAttyHabba has the full confidence of DOJ leadership because she's doing the job – aggressively, independently, and by the book. The district judges should not be swayed by political noise. Keep her in place," Blanche said on X.
Blanche took to X again to defend Habba after the district court declined to extend her tenure.
"The district court judges in NJ are trying to force out @USAttyHabba before her term expires at 11:59 p.m. Friday," Blanche wrote. "Their rush reveals what this was always about: a left-wing agenda, not the rule of law. When judges act like activists, they undermine confidence in our justice system. Alina is President Trump's choice to lead—and no partisan bench can override that."
Attorney General Pam Bondi amplified Blanche's social media post and said in a statement: "My friend @USAttyHabba is doing outstanding work in New Jersey — she makes @thejusticedept proud."
Habba, meanwhile, has faced strong pushback from New Jersey's two Democratic senators over her nomination for U.S. attorney. Senators Cory Booker and Andy Kim have both argued against her confirmation, alleging that Habba has pursued politically motivated prosecutions to serve Trump's agenda.
This is a breaking news story. Updates to follow.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
13 minutes ago
- Newsweek
Russia's New Deadly Glide Bomb Revealed
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Russia has introduced a new guided glide bomb into its full-scale invasion, which marks Moscow's push to develop aerial weapons to bombard Ukraine's infrastructure. Ukrainian authorities said that Russia's new UMPB-5 guided aerial bombs had been dropped by Sukhoi Su-34 fighter jets on two regions in the last two months amid testing of the new weapon. Analysis shared with Newsweek by the Foundation for Defense of Democracies (FDD), a Washington, D.C., think tank, said that the glide bomb was part of Russia's growing efforts to develop cheap standoff guided munitions. Newsweek has contacted the Russian Defense Ministry via email for comment. File photo: Ukrainian rescue workers survey the rubble of a residential building hit during a Russian overnight drone and missile strike in Kyiv, Ukraine on June 23, 2025. File photo: Ukrainian rescue workers survey the rubble of a residential building hit during a Russian overnight drone and missile strike in Kyiv, Ukraine on June 23, It Matters Before Vladimir Putin's full-scale invasion of Ukraine, Moscow underestimated how many glide bombs and other guided munitions it would need. Russia's glide bombs before the war were relatively expensive and so used sparingly. The FDD's John Hardie said Russia's failure to destroy most of Ukraine's air defenses at the invasion's start pushed Moscow to swiftly develop cheap glide bombs with standoff range that will allow its air force to play a greater role. What To Know Ukrainian authorities said the UMPB-5 was first used in Ukraine's Sumy region and then on two consecutive days of strikes on the city of Kharkiv on July 24 and 25; one attack hit a hospital. In the second instance, a Su-34 released the bomb about 65 miles away from Russia's neighboring Belgorod region; this is according to Spartak Borysenko from the Kharkiv Prosecutor's Office, which investigates such attacks as war crimes. Borysenko said Russia is still testing the weapon and that its exact characteristics are not yet known. But the name of the UMPB-5 glide bomb suggests it is a derivative of the UMPB D-30SN, which was first seen in spring 2024, the FDD said. The latter model has a longer range than the 50 miles of its predecessor and has warhead that weighs 2.5 times more, at around 550 pounds. Cheap glide bombs are playing a greater role in Russia's aggression with Moscow; an average of 160 were dropped each day in July 2025, according to President Volodymyr Zelensky—eight times more than spring 2023. The main one used is the UMPK, or "Universal Gliding and Correction Module," first seen in January 2023. It is designed to fit on dumb bombs and was initially employed with the FAB-500 M-62, a 1,100-pound-class high-explosive bomb, but since adapted for bombs of various sizes. Borysenko said that Moscow started using a modified UMPK with larger wings and a range of at least 60 miles in the Sumy and Kharkiv regions in May. With further testing, this range could increase, as suggested by a Russian Telegram channel. Russia is also developing low-cost air-launched cruise missiles, such as the recently unveiled S8000 BanderoL, which can be launched via remotely piloted aircraft. What People Are Saying John Hardie, deputy director of FDD's Russia Program, said Moscow is using a new UMPB-5 guided glide bomb, which: "appears to be a more-powerful derivative of a bomb introduced last year, reflecting the Russian Air Force's efforts to develop a growing variety of cheap standoff guided munitions." Spartak Borysenko, from the Kharkiv Regional Prosecutor's Office, said: "UMPB-5 is a new ammunition that the Russians began using about two months ago … they are currently testing it, and the exact characteristics are not known for certain." What Happens Next Hardie said that details about these new munitions remain scarce, but Russia's Air Force and Naval Aviation are focused on producing large quantities of inexpensive standoff munitions. Whether Russia will address its shortcomings in destroying enemy air defenses is a problem "that will be much harder to solve," Hardie added.
CNN
38 minutes ago
- CNN
UCLA loses federal research funding in administration's ongoing fight with top universities
Race & ethnicityFacebookTweetLink Follow UCLA is the latest major institution of higher learning to see promised research funding snatched away by the Trump administration, the university's leader said in an open letter to students and faculty Thursday. 'This is not only a loss to the researchers who rely on critical grants,' wrote Chancellor Julio Frenk. 'It is a loss for Americans across the nation whose work, health, and future depend on the groundbreaking work we do.' Grants from the National Science Foundation and the National Institutes of Health are included in the suspensions, Frenk said, but did not provide an amount of how much funding is in peril. The Los Angeles Times reported that roughly $200 million in grants awarded to UCLA are being suspended, citing a partial list of suspended grants provided to them by a source. A spokesperson for the National Science Foundation declined to provide specific figures, saying grant awards are being suspended 'because they are not in alignment with current NSF priorities and/or programmatic goals.' 'We will not fund institutions that promote antisemitism,' said a spokesperson for the Department of Health and Human Services, which includes the National Institutes of Health. 'We will use every tool we have to ensure institutions follow the law.' The Trump administration has repeatedly cited antisemitism – especially in the context of contentious pro-Gaza protests on campuses – as a reason to deny promised funds to universities, including Harvard and Columbia. Harvard is fighting the funding decisions in court, while Columbia agreed to a settlement with the government that restored its grants. The funding cut comes days after the Justice Department's Civil Rights Division announced it found UCLA in violation of federal law by 'acting with deliberate indifference in creating a hostile educational environment for Jewish and Israeli students.' While the formal notice to UCLA said the federal government 'now seeks to enter into a voluntary resolution agreement,' Attorney General Pam Bondi sounded less conciliatory. 'DOJ will force UCLA to pay a heavy price for putting Jewish Americans at risk and continue our ongoing investigations into other campuses in the UC system,' Bondi said in a statement. It is not just the Trump administration that has tangled with UCLA over charges of antisemitism. A group of Jewish students filed suit against the university last June, saying the school allowed discrimination against Jews to flourish following Israel's military operation in Gaza in response to the October 7 attacks. The lawsuit said UCLA leaders waited days before responding to a group of pro-Palestinian protesters that refused to allow students to enter campus unless they agreed to 'a statement pledging their allegiance to the activists' views.' UCLA settled the lawsuit earlier this week for $6.45 million, with more than $2 million of the total going to designated 'organizations that combat antisemitism and support the UCLA Jewish community.' UCLA also agreed it is prohibited from 'knowingly allowing or facilitating the exclusion of Jewish students, faculty, and/or staff' from university programs and activities.
CBS News
41 minutes ago
- CBS News
Gov. Josh Shapiro joins lawsuit suing Trump Administration over gender-affirming care
Pennsylvania Governor Josh Shapiro is joining with other state leaders to sue the Trump Administration over gender-affirming care after the U.S. Department of Justice subpoenaed several healthcare clinics and providers. More than 20 doctors and clinics that have been involved in transgender medical care were subpoenaed, and now Governor Shapiro is joining with 16 other Democratic officials suing the Trump Administration over restrictions for gender-affirming care for people under the age of 19. The federal lawsuit filed in Boston alleges that attempts to deny medically necessary healthcare to transgender people through an executive order are unlawful. According to the Department of Justice, however, these investigations include healthcare fraud, false statements, and more, saying those involved in performing these types of procedures on children will be held accountable. The lawsuit claims the Trump Administration is targeting these individuals, as well as alleging the administration has intimidated healthcare providers. It says this order is unlawful because there is no federal statute that bans providing care to minors. UPMC was among those subpoenaed along with others in Pennsylvania. "These actions have made it abundantly clear that our clinicians can no longer provide certain types of gender-affirming care without risk of criminal prosecution," a UPMC spokesperson told KDKA-TV. "This includes specific restrictions on puberty blockers and hormone therapy for individuals under 19." While it is unknown what will come from the lawsuit, UPMC has said they will continue to provide necessary healthcare within the bounds of the law.
